Company Financials

Ondine Biomedical Inc. Financials

Pound sterling

business Ondine Biomedical Inc. Company Profile

Main Stock Listing

LSE: OBI

Market Capitalization None as of None

Market Cap History

Valuations Metrics as of May. 5, 2024

Trailing PE -66.00
Forward PE
Price to Sales TTM £16.57
Price to Book MRQ £279.76
Enterprise to Revenue 9.98
Enterprise to EBITDA -0.44

Financial Reports as of Jun. 30, 2023

Financials

Fiscal Year Ends 2022-12-31
Most Recent Quarter 2023-06-30
Profit Margin 44.98%
Operating Margin -1876.17%
Return on Assets TTM -70.25%
Return on Equity TTM -144.07%

Income Statement

Revenue TTM £470,750
Revenue per Share TTM £0.00
Quarterly Revenue Growth 63.40%
Gross Profit TTM £287,000
EBITDA £-10,636,374
Net Income to Common TTM £-10,950,208
Diluted EPS TTM £-0.06
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ £2,599,078
Total Cash per Share MRQ £0.02
Total Debt MRQ £
Total Debt to Equity MRQ 24.39
Current Ratio MRQ 2.34
Book Value per Share MRQ £0.02

Cash Flow

Operating Cash Flow TTM £-9,441,348
Levered Free Cash Flow TTM £-4,357,438

OBI Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding 226,754,000
Float Shares 98,837,089
Avg 10 Volume 233,897
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 61.50%
% Held by Institutions 9.24%

Stock Price Summary

Beta -0.15
Fifty Two Week Low £4.50
Fifty Two Week High £19.35
Fifty Two Week Change -187.88%
Day 50 MA £8.76
Day 200 MA £10.24

Dividends and Splits

Forward Annual Dividend Rate £
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate £0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date